A multicentre phase III trial to evaluate the safety, tolerabilty, and efficacy of a combination of three antimalaria drugs (artemether-lumefantrine+atovaquone-proguanil) versus two malaria drugs (artemether-lumefantrine) +placebo in African children aged 6-59months with an uncomplicated malaria infection

2021 ◽  
Author(s):  
Oumou Maiga-Ascofaré ◽  
John Amuasi
Sign in / Sign up

Export Citation Format

Share Document